State Board of Administration of Florida Retirement System Boosts Stake in West Pharmaceutical Services, Inc. (WST)

State Board of Administration of Florida Retirement System raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 4.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 92,082 shares of the medical instruments supplier’s stock after acquiring an additional 3,830 shares during the quarter. State Board of Administration of Florida Retirement System owned approximately 0.12% of West Pharmaceutical Services worth $8,864,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of WST. FMR LLC acquired a new position in shares of West Pharmaceutical Services in the first quarter valued at approximately $10,610,000. Teachers Advisors LLC increased its stake in shares of West Pharmaceutical Services by 5.0% in the first quarter. Teachers Advisors LLC now owns 69,274 shares of the medical instruments supplier’s stock valued at $5,653,000 after buying an additional 3,308 shares during the period. Renaissance Technologies LLC acquired a new position in shares of West Pharmaceutical Services in the first quarter valued at approximately $335,000. Eqis Capital Management Inc. acquired a new position in shares of West Pharmaceutical Services in the second quarter valued at approximately $314,000. Finally, Oregon Public Employees Retirement Fund increased its stake in shares of West Pharmaceutical Services by 4.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 26,722 shares of the medical instruments supplier’s stock valued at $2,526,000 after buying an additional 1,100 shares during the period. 91.02% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This article was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://sportsperspectives.com/2017/11/13/state-board-of-administration-of-florida-retirement-system-boosts-stake-in-west-pharmaceutical-services-inc-wst.html.

Several research analysts have recently issued reports on WST shares. Zacks Investment Research downgraded West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Wednesday, July 19th. BidaskClub downgraded West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Jefferies Group LLC raised West Pharmaceutical Services from a “hold” rating to a “buy” rating and upped their price objective for the company from $96.00 to $115.00 in a research note on Friday, September 15th. Stephens started coverage on West Pharmaceutical Services in a research note on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 price objective for the company. Finally, Bank of America Corporation downgraded West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price objective for the company. in a research note on Tuesday, October 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company’s stock. West Pharmaceutical Services currently has a consensus rating of “Hold” and an average target price of $106.00.

Shares of West Pharmaceutical Services, Inc. (NYSE:WST) opened at $101.65 on Monday. The firm has a market cap of $7,547.81, a P/E ratio of 43.81, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The company has a current ratio of 2.59, a quick ratio of 1.87 and a debt-to-equity ratio of 0.15. West Pharmaceutical Services, Inc. has a 52-week low of $76.87 and a 52-week high of $103.36.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.14. The business had revenue of $398.20 million during the quarter, compared to the consensus estimate of $386.02 million. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.53 EPS. equities research analysts forecast that West Pharmaceutical Services, Inc. will post 2.76 earnings per share for the current fiscal year.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply